Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Kurt C Gunter"'
Autor:
Felipe Suarez, Hun Ju Lee, Cliona M. Rooney, Daniel Y Lee, Helen E. Heslop, Hye Jin Kang, Dok Hyun Yoon, Shannon Inman, Kirit M. Ardeshna, Cheolwon Suh, Pierluigi Porcu, Katherin E Combs, Seok Jin Kim, Arnaud Jaccard, Ranjana H. Advani, Yasuhiro Oki, Catherine M. Bollard, Yi Lin, Jin Seok Kim, Eric D. Jacobsen, Maryann Murray, Kurt C. Gunter, Emmanuel Bachy, John Radford, Jonathan E. Brammer, Jia Ruan, Lihua E. Budde, Sang Eun Yoon, Won Seog Kim
Publikováno v:
Annals of Hematology. 100:2529-2539
We conducted a phase II clinical trial to develop an autologous EBV-specific T cell product (baltaleucel T) for advanced, relapsed ENKTL. Among 47 patients who provided whole blood starting material for manufacturing the product, 15 patients received
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3cfd8ba0f89fc29ed5db129ee775ec0
https://doi.org/10.1007/s00277-021-04558-0
https://doi.org/10.1007/s00277-021-04558-0
Publikováno v:
Cytotherapy. 21:699-724
Cellular & Gene Therapies (CGTs) are complex products, which have been key foci of the International Society for Cell & Gene Therapy (ISCT). For this ISCT North American Legal & Regulatory Affairs Committee review publication, CGTs include but are no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d569c8abf99ef4992bf92aa2ae7c75d
https://doi.org/10.1016/j.jcyt.2019.04.002
https://doi.org/10.1016/j.jcyt.2019.04.002
Publikováno v:
Cytotherapy. 18:138-142
Rubius Therapeutics, Cambridge, Massachusetts, USA. Past Chair, International Society for Cellular Therapy (ISCT) Commercialization Committee 2010–2014, Cell Medica Inc., Houston,Texas, USA. Immediate Past ISCT President, 2012–2014, and Chair, IS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e0fcc0cb8c2bbda4bd387cf2672c8f1
https://doi.org/10.1016/j.jcyt.2015.11.001
https://doi.org/10.1016/j.jcyt.2015.11.001
Autor:
Hans J. Stauss, Asim Khwaja, Shao-An Xue, Waseem Qasim, Jacqueline Barry, Emma Nicholson, Michelle Quaye, Stephen D. Robinson, Terri Gaskell, Mandana Ahmadi, Judith King, Francesca Sillito, Nourredine Himoudi, Angelika Holler, Thomas A. Fox, Shannon Inman, Rita Tendeiro-Rego, Ronjon Chakraverty, Kirsty Thomson, Hong Zhan, Panagiotis D. Kottaridis, Emma C. Morris, Natalie Mount, Kurt C. Gunter, Irma Alicia Martínez-Dávila, Andres Virchis, Michaela Sharpe, Sharyn Thomas, Rachel Richardson
Publikováno v:
Blood. 134:1367-1367
Background:Patients with acute myeloid leukemia (AML), myelodysplasia (MDS) or tyrosine kinase inhibitor resistant chronic myeloid leukemia (CML) who are unsuitable for consolidative allogeneic stem cell transplantation (alloSCT) have high relapse ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bec953240e8f471a059d20ee43b0338a
https://doi.org/10.1182/blood-2019-128044
https://doi.org/10.1182/blood-2019-128044
Autor:
Kurt C Gunter, Françoise Horand, Robert S. Franco, José M. Lanao, Emmanuelle Dufour, Elena I. Sinauridze, Alice Banz, Olexii A Skorokhod, Elena Kosenko, Yann Godfrin, Victor Vitvitsky, Vanessa Bourgeaux, Bridget E. Bax
Publikováno v:
Expert Opinion on Biological Therapy. 12:127-133
The first human transfusion was performed by the pioneer Dr Jean-Baptiste Denis in France in 1667 and now, three centuries later, around 50 millions blood units are transfused every year, saving millions of lives. Today, there is a new application fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::818b2ab60470131b366373e187bc8390
https://doi.org/10.1517/14712598.2012.631909
https://doi.org/10.1517/14712598.2012.631909
Autor:
Leigh Turner, Lynn O'Donnell, Robert J. Deans, Robert E. Nordon, Kurt C. Gunter, William E. Janssen, Massimo Dominici, Steve D. Wilton, Edwin M. Horwitz, John E.J. Rasko, Dominic Wall, Edwin Wagena, Milton A. Ruiz, D.L. Griffin, Miguel Forte, Christopher E. Mason, Karen Nichols, Daniel J. Weiss, Hong Nerng Ho, Alok Srivastava, Paul Eldridge, Aaron D. Levine, Natividad Cuende
Publikováno v:
Cytotherapy. 17(12)
Currently, there are many unproven or insufficiently proven cell-based treatments commercially available for hopeful individuals seeking cures for a variety of conditions. Typically, these so-called “therapies” are currently being advertised, sol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca6e51b574c2ad814321f70f2cdb27f8
https://pubmed.ncbi.nlm.nih.gov/26589750
https://pubmed.ncbi.nlm.nih.gov/26589750
Autor:
Catherine M. Bollard, Karen L. Hodgkin, Carlos A. Ramos, Helen E. Heslop, Shannon Inman, Sandhya Sharma, Birju Mehta, Fnu Spoorthi, Serena K. Perna, Vicky Torrano, Kurt C. Gunter, Rayne H. Rouce, Malcolm K. Brenner, Adrian P. Gee, Cliona M. Rooney, Natalia Lapteva, Benjamin Shin
Publikováno v:
Blood. 128:2990-2990
Up to 30 % of Hodgkin and non-Hodgkin lymphomas carry the Epstein Barr virus (EBV) genome and express the viral latency type 2 proteins EBNA-1, LMP-1, LMP-2 and BARF-1 in a pattern termed Type 2 latency. We have previously shown that Epstein-Barr vir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8cb24f9e1122cd70feec69742f2a3db3
https://doi.org/10.1182/blood.v128.22.2990.2990
https://doi.org/10.1182/blood.v128.22.2990.2990
Autor:
Margaret Tillett, Clifford F. Melick, Barbara Poniatowski, Gary I. Cohen, Kurt C. Gunter, Rebecca Haley, Susan Erickson, Ellen Carr
Publikováno v:
Journal of Clinical Apheresis. 13:23-27
The purpose of this in vitro study was to determine whether the Gemini PC-2TX infusion pump could safely deliver peripheral stem cells (PSC) for an autologous PSC transplant. For purposes of hypothesis testing, it was assumed that there would be no s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4deda08625ce3f6a8410844b96802a9
https://doi.org/10.1002/(sici)1098-1101(1998)13:1<23::aid-jca5>3.0.co
https://doi.org/10.1002/(sici)1098-1101(1998)13:1<23::aid-jca5>3.0.co
Autor:
Kurt C. Gunter, Robert C. Rock
Publikováno v:
Therapeutic Drug Monitoring. 17:189-194
The clinical laboratory plays an important part in the development of new pharmaceutical agents. The nature of this role will vary depending on the stage of clinical development of the drug and the goals of a particular investigation. Therefore, it m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d77d1b175052adbee48b98fa69787ce6
https://doi.org/10.1097/00007691-199504000-00015
https://doi.org/10.1097/00007691-199504000-00015
Autor:
Scott R. Burger, Robert J. Deans, Tracey Lodie, René Lardenoije, Mark Bonyhadi, Christopher E. Mason, Dawn Driscoll, Ralf Huss, Timothy E Allsopp, Kurt C. Gunter, Jon A. Rowley, Melissa Carpenter, Tara Clark, John E.J. Rasko, Richard T. Maziarz, Ed Field, Richard Neubiser, Charles S. Cox
Publikováno v:
Cytotherapy. 12(7)
The last decade has seen a dramatic rise in the development of new cellular therapeutics in a wide range of indications. There have been acceptable safety profi les reported in early studies using blood-derived and adherent stem cell products, but al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b9d720f23fd562eefbfd3d614ae8915
https://pubmed.ncbi.nlm.nih.gov/20942603
https://pubmed.ncbi.nlm.nih.gov/20942603